I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

APVRS 2026

We will be contributing to topics related to
-
06:20 AM
Duration 5mins Gold Coast, Australia
Effectiveness and Safety of Faricimab▼ in Eyes With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (nAMD) Over 2 Years: Results From the UK Faricimab Real-World Evidence (FARWIDE) Study
Kenneth Fong, Sobha Sivaprasad, Tunde Peto, Rhianon Reynolds, Clare Bailey, Louise Downey, Ian Pearce, Christine Kiire, Gabriella de Salvo, Deepali Varma, James Talks, Praveen J. Patel, Samantha R. de Silva, Richard P. Gale, Martin McKibbin, Gloria C. Chi, Abigail Darnell, Amanda Downey, Melanie Dodds, Parul Dayal
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:30 AM
Duration 5mins Gold Coast, Australia
Better Visual Outcomes With Faricimab▼ vs Aflibercept 2 mg in Patients With Treatment-Naïve Neovascular Age-Related Macular Degeneration (nAMD) Who Had Small Lesions: A TENAYA/LUCERNE Post Hoc Analysis
De-Kuang Hwang, Amer Omar, Eric Nudleman, Nicholas Dagincourt, Florie Mar, Shriji Patel, Philippe Margaron
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:05 AM
Duration 5mins Gold Coast, Australia
Faricimab▼ for Polypoidal Choroidal Vasculopathy (PCV): Two-Year Results From the SALWEEN Trial
Gemmy Cheung, Timothy Y. Y. Lai, Shih-Jen Chen, Shigeru Honda, Adrian Hock Chuan Koh, Won Ki Lee, Xiaorong Li, Paisan Ruamviboonsuk, Min Sagong, Xiaodong Sun, Yasuo Yanagi, Ruobing Bai, Xiaoying Yang, Philippe Margaron
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:33 PM
Duration 3mins Gold Coast, Australia
One-Year Outcomes of Faricimab▼ Patients With Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) From a Global, Prospective Observational Study: The VOYAGER Study
Robyn Guymer, Aires Lobo, Clare Bailey, Voraporn Chaikitmongkol, Varun Chaudhary, Gloria C. Chi, Robert P. Finger, Susumu Ishida, Adrian Hock Chuan Koh, Monica Lövestam-Adrian, Jose D. Luna Pinto, Steffen Schmitz-Valckenberg, Diane Uschner, Jörn Schweitzer, Veeral Sheth, Eric H. Souied
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:00 PM
Duration 3mins Gold Coast, Australia
Anatomical Outcomes Of Faricimab▼ In Patients With Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME): 6-month Real-world Imaging From The VOYAGER Study
Adrian Hock Chuan Koh, Robert P. Finger, Susumu Ishida, Steffen Schmitz-Valckenberg, Mariacristina Parravano, Clare Bailey, Voraporn Chaikitmongkol, Varun Chaudhary, Nripun Sredar, Gloria C. Chi, Amanda Downey, Thomas Albrecht, Diane Uschner, Monica Lövestam-Adrian, Jose D. Luna Pinto, Jörn Schweitzer, Veeral Sheth, Eric H. Souied, Robyn Guymer
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
12:21 AM
Duration 3mins Gold Coast, Australia
Impact of Baseline Subretinal Fluid (SRF) on Treatment Outcomes in Diabetic Macular Edema (DME): Analysis of the Phase 3 YOSEMITE and RHINE Trials
Jeeyun Ahn, Rolake Alabi, Lei Han, Alexandra Warter, Manuel Amador, Kara Gibson
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
12:33 AM
Duration 3mins Gold Coast, Australia
Reduction in Subretinal Hyperreflective Material (SHRM) With Faricimab▼ vs Aflibercept 2 mg in Treatment-Naïve Neovascular Age-related Macular Degeneration (nAMD)
Se Joon Woo, Sean Adrean, Srinivas Sadda, Jesse Jung, Isabel Bachmeier, Anh Nguyen Duc, Lei Han, Andreas Maunz, Shriji Patel, Siqing Yu, Philippe Margaron
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:35 PM
Duration 5mins Gold Coast, Australia
Efficacy and Safety of Vamikibart in Patients With Uveitic Macular Edema: Pooled Results from the Phase 3 MEERKAT and SANDCAT Trials
Lyndell L. Lim, Glenn J. Jaffe, Eric B. Suhler, Rahul N. Khurana, Carlos Pavesio, Koh-Hei Sonoda, Mark Lomax, Deanna Galloway, Emma Harrell, Marina Mesquida, Zdenka Haskova, David Silverman, Ivo Stoilov, André Vicente, Laura Steeples, Nisha Acharya
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 5mins Gold Coast, Australia
A Synthesis of Real‑World Evidence From the J‑CAT Studies: Treatment Patterns, Complication/Adverse Event Risks, and Economic Burden in Non‑Infectious Uveitis (NIU) in Japan
Sentaro Kusuhara, Koh-Hei Sonoda, Toshikatsu Kaburaki, Tachie Fujita, Saki Katayama, Mariko Nio, Takao Nakamura,Takashi Omoto, Yukari Matsuo-Tezuka, Misako Makishima, Tomoki Yoshizaki, Yuji Fujisawa, Mio Kitamura, Kensuke Sasaki, Kairi Ri, Keiko Sato,Hiroshi Goto
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:18 AM
Duration 3mins Gold Coast, Australia
Improved Vascular Stability Biomarkers With Faricimab▼ Vs Aflibercept 2 mg Using Automated Quantification On Ultra-Widefield Fluorescein Angiography (UWFA), Color Fundus Photography (CFP) and Optical Coherence Tomography (OCT)
Hemal Mehta, Murtaza Adam, Justis P. Ehlers, Andreas Pollreisz, Prethy Rao, Colin S. Tan, Gavin S. Tan, Thomas Albrecht, Manuel Amador, Fethallah Benmansour, Florie A. Mar, Dawn A. Sim, Ming Yang, and Kara Gibson
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon